Literature DB >> 26056379

Aerobactin, but not yersiniabactin, salmochelin, or enterobactin, enables the growth/survival of hypervirulent (hypermucoviscous) Klebsiella pneumoniae ex vivo and in vivo.

Thomas A Russo1, Ruth Olson2, Ulrike MacDonald2, Janet Beanan2, Bruce A Davidson3.   

Abstract

The siderophore aerobactin is the dominant siderophore produced by hypervirulent Klebsiella pneumoniae (hvKP) and was previously shown to be a major virulence factor in systemic infection. However, strains of hvKP commonly produce the additional siderophores yersiniabactin, salmochelin, and enterobactin. The roles of these siderophores in hvKP infection have not been optimally defined. To that end, site-specific gene disruptions were created in hvKP1 (wild type), resulting in the generation of hvKP1ΔiucA (aerobactin deficient), hvKP1ΔiroB (salmochelin deficient), hvKP1ΔentB (enterobactin and salmochelin deficient), hvKP1Δirp2 (yersiniabactin deficient), and hvKP1ΔentBΔirp2 (enterobactin, salmochelin, and yersiniabactin deficient). The growth/survival of these constructs was compared to that of their wild-type parent hvKP1 ex vivo in human ascites fluid, human serum, and human urine and in vivo in mouse systemic infection and pulmonary challenge models. Interestingly, in contrast to aerobactin, the inability to produce enterobactin, salmochelin, or yersiniabactin individually or in combination did not decrease the ex vivo growth/survival in human ascites or serum or decrease virulence in the in vivo infection models. Surprisingly, none of the siderophores increased growth in human urine. In human ascites fluid supplemented with exogenous siderophores, siderophores increased the growth of hvKP1ΔiucA, with the relative activity being enterobactin > aerobactin > yersiniabactin > salmochelin, suggesting that the contribution of aerobactin to virulence is dependent on both innate biologic activity and quantity produced. Taken together, these data confirm and extend a role for aerobactin as a critical virulence factor for hvKP. Since it appears that aerobactin production is a defining trait of hvKP strains, this factor is a potential antivirulence target.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26056379      PMCID: PMC4496593          DOI: 10.1128/IAI.00430-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Redundancy and specificity of Escherichia coli iron acquisition systems during urinary tract infection.

Authors:  Erin C Garcia; Ariel R Brumbaugh; Harry L T Mobley
Journal:  Infect Immun       Date:  2011-01-10       Impact factor: 3.441

2.  Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumonia: an emerging and under-recognized pathogenic variant.

Authors:  D K Pomakova; C-B Hsiao; J M Beanan; R Olson; U MacDonald; Y Keynan; T A Russo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-15       Impact factor: 3.267

3.  Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2.

Authors:  Michael A Bachman; Jennifer E Oyler; Samuel H Burns; Mélissa Caza; François Lépine; Charles M Dozois; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

4.  RmpA regulation of capsular polysaccharide biosynthesis in Klebsiella pneumoniae CG43.

Authors:  H Y Cheng; Y S Chen; C Y Wu; H Y Chang; Y C Lai; H L Peng
Journal:  J Bacteriol       Date:  2010-04-09       Impact factor: 3.490

5.  Virulence and transferability of resistance determinants in a novel Klebsiella pneumoniae sequence type 1137 in China.

Authors:  Yang Liu; Xiang-Yang Li; La-Gen Wan; Wei-Yan Jiang; Jing-Hong Yang; Fang-Qu Li
Journal:  Microb Drug Resist       Date:  2013-11-16       Impact factor: 3.431

6.  Mucoid phenotype of Klebsiella pneumoniae is a plasmid-encoded virulence factor.

Authors:  X Nassif; J M Fournier; J Arondel; P J Sansonetti
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

7.  Primary liver abscess due to Klebsiella pneumoniae in Taiwan.

Authors:  J H Wang; Y C Liu; S S Lee; M Y Yen; Y S Chen; J H Wang; S R Wann; H H Lin
Journal:  Clin Infect Dis       Date:  1998-06       Impact factor: 9.079

8.  Hypervirulent K. pneumoniae secretes more and more active iron-acquisition molecules than "classical" K. pneumoniae thereby enhancing its virulence.

Authors:  Thomas A Russo; Alyssa S Shon; Janet M Beanan; Ruth Olson; Ulrike MacDonald; Alexander O Pomakov; Mark P Visitacion
Journal:  PLoS One       Date:  2011-10-24       Impact factor: 3.240

9.  Virulent clones of Klebsiella pneumoniae: identification and evolutionary scenario based on genomic and phenotypic characterization.

Authors:  Sylvain Brisse; Cindy Fevre; Virginie Passet; Sylvie Issenhuth-Jeanjean; Régis Tournebize; Laure Diancourt; Patrick Grimont
Journal:  PLoS One       Date:  2009-03-25       Impact factor: 3.240

10.  Vital signs: carbapenem-resistant Enterobacteriaceae.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-03-08       Impact factor: 17.586

View more
  85 in total

1.  Hypervirulent Klebsiella pneumoniae induced ventilator-associated pneumonia in mechanically ventilated patients in China.

Authors:  Q Yan; M Zhou; M Zou; W-e Liu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-11       Impact factor: 3.267

Review 2.  Hypervirulence and hypermucoviscosity: Two different but complementary Klebsiella spp. phenotypes?

Authors:  Juan Carlos Catalán-Nájera; Ulises Garza-Ramos; Humberto Barrios-Camacho
Journal:  Virulence       Date:  2017-04-12       Impact factor: 5.882

Review 3.  Hypervirulent Klebsiella pneumoniae.

Authors:  Thomas A Russo; Candace M Marr
Journal:  Clin Microbiol Rev       Date:  2019-05-15       Impact factor: 26.132

4.  Hypervirulent Klebsiella pneumoniae: a Call for Consensus Definition and International Collaboration.

Authors:  Sohei Harada; Yohei Doi
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

5.  The evolution of three siderophore biosynthetic clusters in environmental and host-associating strains of Pantoea.

Authors:  Craig D Soutar; John Stavrinides
Journal:  Mol Genet Genomics       Date:  2018-07-19       Impact factor: 3.291

6.  High Prevalence of Hypervirulent Klebsiella pneumoniae Infection in China: Geographic Distribution, Clinical Characteristics, and Antimicrobial Resistance.

Authors:  Yawei Zhang; Chunjiang Zhao; Qi Wang; Xiaojuan Wang; Hongbin Chen; Henan Li; Feifei Zhang; Shuguang Li; Ruobing Wang; Hui Wang
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

7.  Aerobactin Synthesis Proteins as Antivirulence Targets in Hypervirulent Klebsiella pneumoniae.

Authors:  Thomas A Russo; Andrew M Gulick
Journal:  ACS Infect Dis       Date:  2019-04-29       Impact factor: 5.084

8.  Clinical and virulence factors related to the 30-day mortality of Klebsiella pneumoniae bacteremia at a tertiary hospital: a case-control study.

Authors:  Hiroki Namikawa; Makoto Niki; Mamiko Niki; Koichi Yamada; Kiyotaka Nakaie; Arata Sakiyama; Ken-Ichi Oinuma; Taishi Tsubouchi; Yoshihiro Tochino; Yasuhiko Takemoto; Yukihiro Kaneko; Taichi Shuto; Hiroshi Kakeya
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-10-11       Impact factor: 3.267

9.  Risk factors and clinical outcomes of hypervirulent Klebsiella pneumoniae induced bloodstream infections.

Authors:  Jiayang Li; Jianan Ren; Weiping Wang; Gefei Wang; Guosheng Gu; Xiuwen Wu; Ying Wang; Mei Huang; Jieshou Li
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-12-14       Impact factor: 3.267

10.  Molecular epidemiology of virulence and antimicrobial resistance determinants in Klebsiella pneumoniae from hospitalised patients in Kilimanjaro, Tanzania.

Authors:  Tolbert Sonda; Happiness Kumburu; Marco van Zwetselaar; Michael Alifrangis; Blandina T Mmbaga; Ole Lund; Gibson S Kibiki; Frank M Aarestrup
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-07-20       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.